RECARBRIO 250 mg/100mL (Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous INJECTION, POWDER, FOR SOLUTION) 250 mg/100mL

RECARBRIO 250 mg/100mL is an intravenous powder for solution containing imipenem, cilastatin, and relebactam. It is used to treat bacterial infections. This combination medication is designed for hospital use and requires professional administration.

Strength

250 mg/100mL

Pack Size

25 VIAL, SINGLE-DOSE in 1 CARTON (0006-3856-02) / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RECARBRIO 250 mg/100mL is primarily used for the treatment of bacterial infections. The combination of imipenem, cilastatin, and relebactam works together to combat a range of bacterial strains. This medication is often prescribed for severe infections that require intravenous administration. Patients typically receive this treatment in a hospital setting under the supervision of healthcare professionals.

Side Effects

Common effects of RECARBRIO 250 mg/100mL may include gastrointestinal discomfort, such as nausea or diarrhea. Some patients might experience allergic reactions or changes in blood cell counts. It is important to monitor for any adverse reactions and report them to a healthcare provider promptly.

Precautions & Warnings

RECARBRIO 250 mg/100mL should be handled with care, as it is intended for professional use only. Patients with a history of allergic reactions to similar antibiotics should inform their healthcare provider before treatment. Proper storage and preparation are crucial to maintain the medication's effectiveness and safety.

Avoid Interactions

RECARBRIO 250 mg/100mL may interact with other medications, including certain antibiotics and drugs that affect kidney function. Alcohol and other substances that can cause liver damage should be avoided during treatment. Always consult a healthcare provider about potential interactions before starting this medication.

Frequently Asked Questions

RECARBRIO 250 mg/100mL is used to treat bacterial infections, typically in a hospital setting.

RECARBRIO 250 mg/100mL is administered intravenously as a powder for solution.

Common side effects may include gastrointestinal discomfort, nausea, and diarrhea.

RECARBRIO 250 mg/100mL is typically used in a hospital setting under professional supervision.

If you experience an allergic reaction, seek immediate medical attention and inform your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.